Next Fifteen Communications Plc
Next Fifteen Communications Group plc ("Next Fifteen" or the "Company")
announces that 92,251 new ordinary shares of 2.5 pence each ("Ordinary Shares")
have been allotted pursuant to the acquisition of Credo Communications Limited
("Credo").
On 4 January 2006, Next Fifteen announced the completion of the acquisition of
Credo. Under the terms of the acquisition, part of the total consideration is
payable 12 months following completion, part of which is in Next Fifteen shares.
In accordance with this, 92,251 Ordinary Shares are being allotted in respect of
this payment.
Application has been made to the London Stock Exchange for the new Ordinary
Shares to be admitted to AIM and it is expected that admission will take place
on 8 January 2007. Following the admission to trading of the Shares, the Company
will have 53,364,147 Ordinary Shares in issue.
Enquiries:
-0-
*T
Next Fifteen
Mark Sanford, Company Secretary 020 8846 0778
Bridgewell 020 7003 3000
John Craven, Managing Director
Fred Ward, Director
*T
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.